Structural optimization and de novo design of dengue virus entry inhibitory peptides - Wikidata - awgldk - TriplyDB

Structural optimization and de novo design of dengue virus entry inhibitory peptides

Structural optimization and de novo design of dengue virus entry inhibitory peptides

http://www.wikidata.org/entity/Q28474595

about

Release of dengue virus genome induced by a peptide inhibitor Flaviviruses: braking the entering Carbohydrate-related inhibitors of dengue virus entry Sulfated polysaccharide, curdlan sulfate, efficiently prevents entry/fusion and restricts antibody-dependent enhancement of dengue virus infection in vitro: a possible candidate for clinical application Inhibition of influenza A virus infection in vitro by peptides designed in silico Progress in the identification of dengue virus entry/fusion inhibitors Novel approaches to flavivirus drug discovery.Detection and typing of viruses using broadly sensitive cocktail-PCR and mass spectrometric cataloging: demonstration with dengue virus.Mechanistic study of broadly neutralizing human monoclonal antibodies against dengue virus that target the fusion loop.A fusion-inhibiting peptide against Rift Valley fever virus inhibits multiple, diverse viruses.Anti-dengue virus serotype 2 activity and mode of action of a novel peptide.Identification of Peptide Inhibitors of Enveloped Viruses Using Support Vector Machine.Cholesterol-conjugated peptide antivirals: a path to a rapid response to emerging viral diseases.New developments in flavivirus drug discovery.Combating Ebola with Repurposed Therapeutics Using the CANDO Platform.A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against dengue virus infection.Peptide inhibitors against dengue virus infection.Inhibition of dengue virus entry into target cells using synthetic antiviral peptides.Computational identification of self-inhibitory peptides from envelope proteins.Dengue virus entry as target for antiviral therapy.Peptides as Therapeutic Agents for Dengue Virus.Recent advances in the development of antiviral therapeutics for Rift Valley fever virus infection.Strategies Using Bio-Layer Interferometry Biosensor Technology for Vaccine Research and Development.

P2860

Q26248897-B1238558-61EE-47E3-AF55-30C31765739E Q26852435-FE0F4BD8-76A9-4639-A7DD-D1B979FABC41 Q26864413-07192A29-35EE-47E3-AF39-77E6B2E0C23D Q28486916-BF5F75A8-469F-491A-BADA-77CC5A83A3CD Q28534343-1787AEC7-052F-4D51-A6CE-05926C221BFC Q34054616-CB8B8B2D-5E77-454D-A23C-686EC8AC5D48 Q34206832-8C6D7A90-E38A-4191-83EA-0E533BA1315E Q34266774-4CDD08CB-E0DA-4072-81DF-0DEF0FCD94B5 Q34306877-4CEC1A67-C7CD-44E1-BB25-A22585F3A15F Q34999859-9287C335-E6B6-470E-BB7C-727CCBB89AAA Q35739141-FFB8BCDA-5663-4AD6-B11A-8DEC8B1F8F4F Q35860797-A890CEA4-2923-43B5-AD59-1E73E30ECCEB Q38261556-46B17591-44C1-4CA6-8CF7-57ACC1B4F273 Q38769771-83124183-5D24-4E2B-AA31-EDA9454CC410 Q38789466-99FE8A2F-384F-41D0-8244-0E114EA197E8 Q38884987-5E0377C0-E6D5-4A09-AEA6-90F30FE53B00 Q39017020-F8AE5A17-C796-4E16-985B-CDBFD14242F9 Q40180290-C06E2A17-5E45-4A9B-B850-E3A13D92E913 Q40288667-168CE377-245F-42BA-962C-0CDAEB2AB819 Q40289267-3C837C4C-E006-4044-943D-D26249E292C1 Q45323856-6CA5DBF3-9325-4793-B7AE-D1BBC134DBD7 Q45324172-E2D26799-915E-423F-9CAF-734F94C2E845 Q47171892-69F2C53A-998E-46B4-B20A-C35F7637F248

P2860

Structural optimization and de novo design of dengue virus entry inhibitory peptides

http://www.wikidata.org/entity/Q28474595

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Structural optimization and de novo design of dengue virus entry inhibitory peptides

@ast

Structural optimization and de novo design of dengue virus entry inhibitory peptides

@en

Structural optimization and de novo design of dengue virus entry inhibitory peptides

@nl

type

label

Structural optimization and de novo design of dengue virus entry inhibitory peptides

@ast

Structural optimization and de novo design of dengue virus entry inhibitory peptides

@en

Structural optimization and de novo design of dengue virus entry inhibitory peptides

@nl

prefLabel

Structural optimization and de novo design of dengue virus entry inhibitory peptides

@ast

Structural optimization and de novo design of dengue virus entry inhibitory peptides

@en

Structural optimization and de novo design of dengue virus entry inhibitory peptides

@nl

P1433

Q28474595-30C8003A-9ADC-4FC9-9780-CBBBAB8CADA8

P1476

Q28474595-1A72CC5B-7AFF-4797-82AE-825EAA616C15

P2093

Q28474595-00C6C5C9-EDF2-4731-9853-80910C5A7FA8

Q28474595-1D3824B0-3BDE-4C4F-9E19-939A52365301

Q28474595-5085BDC0-3F08-4B37-8547-BE48A54FEC73

Q28474595-7CA3CA02-6B80-4D50-8F2C-B65A71173A29

Q28474595-9A2DB5E8-A09E-43DE-818E-84061E5DC5CB

Q28474595-CEF4011A-4417-40EC-AEE2-2C6C8C21727D

Q28474595-EBA4F60B-6D89-4304-946B-112C1D2142BD

Q28474595-FE302378-D7AC-4CFB-8327-D73A7E4685CB

P2860

Q28474595-15E26E24-CBAD-4EC2-B887-8E4F0F94B423

Q28474595-189DCAA6-B99B-4FA9-86A5-3713705746D6

Q28474595-1D2D3C13-0FB0-4FE1-8697-679E8E9C1ADC

Q28474595-1F5B7D1C-DE7F-4E25-86AD-A2C6C189EB9B

Q28474595-26B4F454-D3A2-4F5D-8EAC-2BBFAE452767

Q28474595-29B12FA5-8853-464B-9C8E-63EB0D09DBC2

Q28474595-32692CD3-6D0E-4F96-BB0C-A8ADD6061046

Q28474595-35F827B2-6018-43DC-AD15-D64506FDB2D1

Q28474595-39678766-873A-46F5-9130-6F290D6FBBB2

Q28474595-39BF70EF-6632-4566-AAE5-4946A8C83C4D

P304

Q28474595-964803F7-C34C-4B49-82D4-A7E471D756D1

P31

Q28474595-BEA79E39-87E0-4659-AE59-489A9EE4B14E

P356

Q28474595-C91FBA0A-1CD2-4D11-B993-81DCD90AA412

P407

Q28474595-E0CF649A-9396-4B30-812C-5D07CFFA224F

P433

Q28474595-BD78971E-2C7E-4CC0-9AE3-D68CE57FA768

P478

Q28474595-8DC8A586-C80A-47F6-BAD7-A0ED38E8D4A8

P50

Q28474595-7774842D-D75A-4A9D-8DF5-28087FC586D6

Q28474595-9CA5B73A-7D99-4317-903F-76F8DC81E278

Q28474595-D72FC8DC-272E-4B05-B9ED-0D78C1E14421

P577

Q28474595-FC55EF00-CCD4-4324-88A3-750C109303BA

P5875

Q28474595-AA1CF076-4684-405E-8027-EFA8482F2E10

P698

Q28474595-64A169AB-B262-49A5-99AE-1D3A118D1BFA

P921

Q28474595-0FC1ED1C-7B05-4AA6-A73D-69DA197BBB42

Q28474595-ABF97044-6ED0-4A90-8BA0-6783BD863658

P932

Q28474595-EB765372-85A5-47ED-B518-3E0D39E7C61B

P356

JOURNAL.PNTD.0000721

P1433

PLOS Neglected Tropical Diseases

P1476

Structural optimization and de novo design of dengue virus entry inhibitory peptides

@en

P2093

Craig R Rees

http://www.w3.org/2001/XMLSchema#string

Ekachai Jenwitheesuk

http://www.w3.org/2001/XMLSchema#string

Elizabeth Hunsperger

http://www.w3.org/2001/XMLSchema#string

Joshua M Costin

http://www.w3.org/2001/XMLSchema#string

Kelly A Conrads

http://www.w3.org/2001/XMLSchema#string

Krystal A Fontaine

http://www.w3.org/2001/XMLSchema#string

Ram Samudrala

http://www.w3.org/2001/XMLSchema#string

Shee-Mei Lok

http://www.w3.org/2001/XMLSchema#string

P2860

Castanospermine, a potent inhibitor of dengue virus infection in vitro and in vivo

Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses

Peptide inhibitors of dengue virus and West Nile virus infectivity

Differences in the postfusion conformations of full-length and truncated class II fusion protein E of tick-borne encephalitis virus.

Crystal Structure of West Nile Virus Envelope Glycoprotein Reveals Viral Surface Epitopes

Crystal Structure of the West Nile Virus Envelope Glycoprotein

A ligand-binding pocket in the dengue virus envelope glycoprotein

Antiviral Peptides Targeting the West Nile Virus Envelope Protein

Solution structure of the envelope protein domain III of dengue-4 virus

The flavivirus envelope protein E: isolation of a soluble form from tick-borne encephalitis virus and its crystallization

P304

e721

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PNTD.0000721

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Michael Rossmann

Scott F Michael

P577

2010-06-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44804072

http://www.w3.org/2001/XMLSchema#string

P698

20582308

http://www.w3.org/2001/XMLSchema#string

P921

infectious disease

P932

2889824

http://www.w3.org/2001/XMLSchema#string